[144] Veris Residential, Inc. SEC Filing

Rhea-AI Filing Summary

Veris Residential, Inc. (VRE) submitted a Form 144 notice for a proposed sale of 114,560 shares of common stock through Morgan Stanley Smith Barney LLC, planned on 09/11/2025. The filing reports an aggregate market value of $1,840,956.29 and notes 93,421,769 shares outstanding. The securities listed were largely acquired in October–November 2018 via open-market purchases, with multiple lots paid in cash. The filing also discloses several recent sales during September 2025 by related entities, showing gross proceeds between roughly $1.03m and $1.38m per trade. The filer certifies there is no undisclosed material adverse information at the time of the notice.

Insights

Financial Analyst

TL;DR: Routine Rule 144 notice disclosing a modest-sized proposed stock sale; informational not catalytic.

This Form 144 documents a proposed off-exchange sale of 114,560 common shares with an aggregate market value of $1.84 million, representing roughly 0.12% of the reported 93.4 million outstanding shares. The lots were acquired in 2018 by open-market purchases and paid in cash. Recent executed sales by related entities in September 2025 are disclosed with gross proceeds per trade from ~$1.03 million to ~$1.38 million. From a financial perspective, the filing provides compliance transparency but contains no operating results or new corporate actions that would materially change the investment thesis.

Compliance / Risk Analyst

TL;DR: Filing appears procedurally complete and consistent with Rule 144 disclosure requirements.

The notice identifies the broker, the planned sale date, the class and quantity of securities, acquisition dates and payment method, and recent sales within the past three months. The signer affirms no undisclosed material adverse information. The record of multiple small open-market acquisitions and the signature representation reduce procedural risk; however, the filing itself neither confirms an executed sale on the planned date nor discloses any trading plan adoption date.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	114560	1840956.29	93421769	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/29/2018	Open Market Purchase	Open Market			304	10/31/2018	Cash
Common	10/17/2018	Open Market Purchase	Open Market			4694	10/19/2018	Cash
Common	10/23/2018	Open Market Purchase	Open Market			3762	10/25/2018	Cash
Common	11/05/2018	Open Market Purchase	Open Market			19795	11/07/2018	Cash
Common	11/01/2018	Open Market Purchase	Open Market			5723	11/05/2018	Cash
Common	10/26/2018	Open Market Purchase	Open Market			2026	10/30/2018	Cash
Common	10/18/2018	Open Market Purchase	Open Market			24321	10/22/2018	Cash
Common	10/15/2018	Open Market Purchase	Open Market			29932	10/17/2018	Cash
Common	10/12/2018	Open Market Purchase	Open Market			9835	10/16/2018	Cash
Common	11/02/2018	Open Market Purchase	Open Market			13466	11/06/2018	Cash
Common	10/16/2018	Open Market Purchase	Open Market			702	10/18/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Veris Residential (VRE) disclose?

The Form 144 discloses a proposed sale of 114,560 common shares via Morgan Stanley Smith Barney LLC on 09/11/2025 with an aggregate market value of $1,840,956.29.

How large is the proposed sale relative to VRE's outstanding shares?

The proposed 114,560 shares are reported against 93,421,769 shares outstanding, roughly 0.12% of outstanding shares.

Who acquired the shares and when were they bought?

The filing shows the shares were acquired in multiple open-market purchases in October–November 2018, with amounts and payment dates listed in the table.

Were there recent related sales reported in the filing?

Yes. The filing lists several sales in September 2025 by related entities (MIRELF VII and MIRELF VI) with gross proceeds per trade between approximately $1.03m and $1.38m.

Does the filing state there is undisclosed material information?

The signer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.